Tony Zook serves as Merck’s Executive Director of Product Integrity, with responsibility for the development and execution of the Company’s strategy that protects Merck products from illicit actions, including counterfeiting, diversion, tampering, and theft.
His work focuses on securing the supply chain, investigation and enforcement of illicit activity, and building stakeholder awareness to this growing threat to public safety. He is particularly interested in investigations and forensic analysis of counterfeit medicines, applications of advanced intelligence analytics to support these investigations, and collaborative relationships with regulatory and enforcement agencies who can best mitigate risks to patients.
